We are Cytiva, a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Formerly part of GE Healthcare, we have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020.
Our customers undertake life-saving activities. These range from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services – the pots, pans, soups and sauces – they need to work better, faster and safer, leading to better patient outcomes.
Cellenion is a young and fast-growing team dedicated to precision and speed in single-cell analyses in Lyon. We are part of the CELLINK group.
Founded in 2016, we are a global life-science company that provides technologies, products and services to create, understand, and master cell and molecular biology. With a focus on the application areas of bioprinting, analysis, and liquid handling and bioprocessing, we develop and market innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries. Our products are trusted by more than 1,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 55 countries, and have been cited in more than 150 publications. Join us in creating the future of medicine!
We are driven by three mantras: passion, inspiration and persistence.
Do you want to join a company that develops cutting-edge products for the life science industry? Do you love to work in an interdisciplinary and international team of highly skilled, young, and energetic people?
The Advanced Regenerative Manufacturing Institute (ARMI) is an industry-led public-private partnership that was created to address the technical and workforce development challenges associated with the scalable, consistent, cost-effective manufacture of tissue engineered medical products (TEMPs). As part of its technical effort, ARMI is developing the Tissue Foundry, an automated, modular manufacturing platform with which it will test and validate new manufacturing technologies and support the development of scalable TEMP manufacturing processes according to Quality by Design principles.
ARMI is in need of a Bioprocess Technician to perform cell culture and help optimize manufacturing processes for TEMPs on the ARMI Tissue Foundry. This position will work on transitioning existing manual tissue engineering processes to scalable, automated, closed, manufacturing processes. The Bioprocess Specialist will work cross-functionally both internally and externally. The role will be highly focused in bench lab processing and analysis in order to facilitate the successful tech transfer and automation of various manufacturing processes.
Converting CT/MRI/Echo scans to 3D Printable outputs.
Designing of products such as anatomical models, surgical guides, and implants for patient-specific anatomy.
Maintaining and Running FDM 3D Printers to 3D Print and deliver accurate output.
Passing on any product innovation ideas to the company.
Developing and maintaining relations by meeting surgeons, consultants, radiologists, etc of various segments of the medical field to understand the exact requirements.
Maintaining follow-ups by emails, calls, or visits.
Providing regular updates to the company and maintaining any records for the same.
Basic understanding of the anatomy of the human body.
Good communication skills.
Open to learning new things and provide suggestions for development.
Training will be provided to suit industry requirements.
Prellis Biologics, Inc., is a tissue engineering company in search of an entry-level to mid-entry level scientist to assist in managing our human antibody development program and work with a team developing human tissues in vitro. Experience in a start-up or small pharma or relevant research experience is highly desired.
1) Experimental design, implementation, and analysis.
2) Mammalian cell culture
3) Primary human cell isolation and culture
4) FACS, IHC, and Imaging (Confocal, Light microscope etc.)
5) Long-term cell culture maintenance
6) Experience with bioreactor work and/or BSL-2 work
7) Experience in characterizing tissue structures and differentiated cell types.
8) Animal research and experimental design experience
1) Design and perform research experiments
2) Analyze data
3) Write project reports and present data
4) Work collaboratively with senior scientists to execute company goals
5) Assist with ordering and supply maintenance as necessary
1) Highly motivated
3) Positive Attitude
VIVAX BIO, LLC, based in New York, and its Moscow, Russia, R&D subsidiary, 3D Bioprinting Solutions, focus on 3D bioprinting and work on the whole range of the hardware, materials, technologies, and products comprising the 3D bioprinting industry. We strongly believe that at this stage of the industry development, the synergistic value of integrating the biological and the engineering sides of our business exceeds the potential advantages of specialization. Our product pipeline – from the earliest stages of R&D to commercial manufacturing – includes 3D bioprinters based on different technologies (consistently rated among the top bioprinters in the world) and various tissue and organ constructs. We had printed a murine thyroid gland construct and successfully implanted it into laboratory animals. The company continues working with human cells creating 3D bioprinted tissues and organoid models for drug discovery and disease modeling as a superior alternative to traditional 2D models. At the end of 2018, our proprietary 3D bioprinter, OrganAut, was launched into space on board the International Space Station and performed formative biofabrication of 3D tissue and organ constructs in microgravity, opening for us, among other things, the opportunity to further expand our business to science (B2S) services. In 2018, we started to adapt our existing technologies for cellular agriculture applications. Framework agreements have been signed with several leading startups in the field of clean meat and now we are to carry out several joint experiments using muscle cells of various species.
Shiok Meats is a cell-based crustacean meat startup, the first of its kind in the world (Shiok in Singapore English means delicious and fantastic). Our mission is to bring cell-based crustaceans to your table, which is health-, animal- and environment-friendly, by growing cells instead of animals. Not only will our seafood and meats be delicious and cruelty-free, they will be nutritious and sustainable when compared to farmed or wild-caught seafood.
Shiok Meats is founded by two well accomplished stem cell scientist-turned entrepreneurs and business women, Dr Sandhya Sriram (CEO) and Dr Ka Yi Ling (CSO) – we are happy to meet you to speak about your career goals, aspirations and how you can grow with us!
Shiok Meats is hiring for several roles as below to further our R&D and accelerate commercialization. We hope that you’re as excited about innovation and cell-based seafood as we are and that you look forward to a vibrant working environment with lots of room to grow. You will be an integral part of Shiok Meat’s growth and will help shape our long-term directions.
As a startup organization, we are seeking a Head of Operations with a strong and inspiring presence, who knows what needs to get done and is willing and able to do or delegate the things we haven’t hired for yet. This person is a thought partner to the CEO, driving the execution of the company’s strategic vision and leading internal operations.
The Head of Operations is an integral part of a small team (R&D, product development, business development, and marketing) charged with working together seamlessly to optimally deliver a pipeline of regenerative medical products from idea to approval/sale.
Importantly, the Head of Operations thrives in the warp-speed pace and sometimes messiness of a startup. They are a hands-on yet empowering leader who knows how to build and mentor a stellar team.
Dimension Inx is an emerging leader in biofabrication, the next frontier in medicine. Our 3D-Painting Materials Design and Manufacturing System offers the versatility, manufacturability, and affordability necessary for widespread adoption of tissue-engineered regenerative medical products. We are creating advanced biomaterials and regenerative medical products that fundamentally change how we treat human disease and debilitation.Dimension Inx is an emerging leader in biofabrication, the next frontier in medicine. Our 3D-Painting Materials Design and Manufacturing System offers the versatility, manufacturability, and affordability necessary for widespread adoption of tissue-engineered regenerative medical products. We are creating advanced biomaterials and regenerative medical products that fundamentally change how we treat human disease and debilitation.
Location: Los Angeles, California, USA
Postdoctoral Researcher Position: Cancer and Immunotherapy
Postdoctoral Researcher Position: Flexible Electronics and Microfluidics
Postdoctoral Researcher Position: Microfluidics and Organs on a ChipPostdoctoral Research Position: Biomaterials and Tissue Engineering
To invent and foster practical solutions that restores or enhances the health of individuals.
The Terasaki Institute for Biomedical Innovation envisions a world where personalized medicine is available to all. Every person is unique with individual challenges to optimal health, from genetic predisposition to disease to socioeconomic barriers to care. We strive to address those challenges to bridge the gap between sickness and wellness.
The Terasaki Institute for Biomedical Innovation aims to tackle the biggest problems in health. We are focused on solving problems in new ways, developing ‘personalized’ solutions, prototyping tangible solutions, and bringing our innovation to the real-world.
We recognize that each individual is unique. The effort to diagnose, treat and prevent disease is not a one-size-fits-all endeavor. It requires precision and personalization.
Researchers are making efforts to bringing precision medicine to fruition by collecting omic, environmental, and lifestyle data. Omics, the umbrella term used to describe the fields of genomics, proteomics, metabolomics and other biological sciences that end with –omics, aims to comprehensively understand the cause of disease. Data from omic studies may increase our understanding of how individual variability affects the metabolism of drugs, the effectiveness of treatments, and the risks of disease development.
The Terasaki Institute for Biomedical Innovation will use these omics-driven insights to drive the engineering of precise and personalized solutions. Our goal is to tailor solutions that account for individual variability in a person’s genetic makeup, environment, and lifestyle.
At the Terasaki Institute for Biomedical Innovation, our multidisciplinary teams work as part of a unique convergence ecosystem to quickly translate scientific knowledge into real-world solutions in the clinic. We focus on the problem first and work our way back to the solution. Scientists, clinicians, and engineers work in close collaboration to tackle the problem and rapidly build prototypes. We involve business development and technology transfer experts early on to adapt our innovations for immediate use.
Location: Victoria, British Columbia (Remote work possible, see link for detail)
Axolotl looking for an experienced businessperson to join our team as a Director of Business Development to serve as an integral part of our product launch and business development team located in Victoria, BC. Remote work may be possible for the right candidate. To learn more, visit here.
Axolotl’s mission is to provide turn-key reagents, including bioinks, 3D tissue models, and consulting services in the field of 3D bioprinting to advance the field of tissue engineering and regenerative medicine.
© 2015-2020 - 3DHEALS LLC